Welcome to our dedicated page for AMPHENOL /DE/ SEC filings (Ticker: APH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMPHENOL /DE/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMPHENOL /DE/'s regulatory disclosures and financial reporting.
Amphenol (APH): Shareholder files Form 144 notice to sell stock. A holder named William Doherty filed to sell up to 80,000 shares of Amphenol common stock through Morgan Stanley Smith Barney LLC on or about 10/29/2025. The filing lists an aggregate market value of $11,282,928 for the proposed sale and identifies the NYSE as the exchange.
The shares were acquired on 10/29/2025 via the exercise of options under a registered plan, paid in cash. The filing also reports recent activity over the past three months: 113,000 shares sold on 08/11/2025 for gross proceeds of $12,462,837.80 and 113,000 shares sold on 08/08/2025 for gross proceeds of $12,304,750.80.
Amphenol Corporation launched a primary debt offering of $7.5 billion in senior notes across seven tranches to help finance its planned $10.5 billion cash acquisition of CommScope’s Connectivity and Cable Solutions businesses. Tranches include $500 million floating-rate notes due 2027 at Compounded SOFR + 0.53%, plus fixed-rate notes: $750 million 3.800% due 2027, $750 million 3.900% due 2028, $1.0 billion 4.125% due 2030, $1.25 billion 4.400% due 2033, $1.6 billion 4.625% due 2036, and $1.65 billion 5.300% due 2055.
The company expects approximately $7,431.8 million in net proceeds, to be combined with cash on hand and potential borrowings under delayed draw term loans and/or its U.S. commercial paper program to fund the acquisition and related fees. The offering is not conditioned on closing the deal. If the acquisition is not completed by the specified date or is abandoned, all series are subject to a special mandatory redemption at 101% of principal plus accrued interest. The notes are unsecured senior obligations, include a 101% repurchase upon a Change of Control Repurchase Event, and settle on a T+10 basis.
Amphenol Corporation entered into an underwriting agreement to offer and sell multiple tranches of senior notes totaling $7.5 billion. The deal includes $500,000,000 floating rate notes due 2027, $750,000,000 notes due 2027, $750,000,000 notes due 2028, $1,000,000,000 notes due 2030, $1,250,000,000 notes due 2033, $1,600,000,000 notes due 2036, and $1,650,000,000 notes due 2055.
The closing of the offerings is expected on November 10, 2025, subject to the satisfaction of customary closing conditions. The company also announced the pricing of each series in a press release referenced as Exhibit 99.1. The agreement is filed as Exhibit 1.1 and tied to Registration Statement No. 333-270605.
Amphenol (APH) reported insider transactions by its HES Division President on 10/24/2025. The officer exercised stock options for 212,800 shares at $33.295 and 152,318 shares at $43.25, then sold the same amounts—212,800 and 152,318 shares—at a weighted average price of $134.6508.
The filing notes the sale price was executed in multiple trades ranging from $133.5000 to $136.8375. In addition, 80,000 shares were reported as gifted, with a closing price on the gift date of $133.82. Following these transactions, the officer directly beneficially owned 353,742 shares. Remaining option balances after the exercises were shown in Table II.
Amphenol Corporation reported strong Q3 2025 results. Net sales were $6,194.4, up from $4,038.8 a year ago, and net income attributable to the company was $1,245.7 versus $604.4. Diluted EPS was $0.97 (basic $1.02). For the first nine months, net sales reached $16,655.7 and net income was $3,074.8, reflecting broad growth following recent acquisitions.
Operating cash flow for the nine months was $3,652.5, ending the quarter with cash and equivalents of $3,799.3. Total assets rose to $27,143.0, with total debt of $8,067.1 and long‑term debt of $7,129.5. The company issued $750.0 of 4.375% Senior Notes due 2028 and €600.0 of 3.125% Senior Notes due 2032, repaid its 2.050% Senior Notes due March 2025, and kept new $2,000.0 three‑year and $2,000.0 364‑day delayed draw term loans undrawn, expected for the planned CCS Business acquisition. A quarterly dividend of $0.165 per share was declared. Shares outstanding were 1,224,055,508 as of October 21, 2025. The company also noted tax notices to certain China subsidiaries with aggregate potential exposure up to approximately $200.
Form 144 notice: A shareholder filed to sell up to 365,118 shares of common stock, with an aggregate market value of $49,163,430.79. The filing lists an approximate sale date of 10/24/2025 and identifies the NYSE as the exchange, with Morgan Stanley Smith Barney LLC Executive Financial Services as broker.
The shares were acquired on 10/24/2025 through a cash exercise of options under a registered plan from the issuer. Shares outstanding were 1,220,921,111.
Amphenol Corporation (APH) furnished an 8-K announcing it issued a press release with financial results for the quarter and nine months ended September 30, 2025. The release is provided as Exhibit 99.1 and incorporated by reference.
The information under Item 2.02 is being furnished, not filed, which limits certain liabilities under the Exchange Act. The company also included customary forward-looking statements cautionary language.
Peter Straub, an officer (President, ISS Division) of Amphenol Corporation (APH), reported option exercises and simultaneous open-market sales on 09/08/2025. He exercised two stock option grants: one with a $22.37 exercise price (44,000 shares exercisable 05/23/2020, expiring 05/23/2029) and one with a $22.55 exercise price (44,000 shares exercisable 05/21/2021, expiring 05/21/2030). On the same date he sold 88,000 Class A shares in multiple trades at a weighted average sale price of $110.6357 (individual trades ranged $110.55–$111.035). After these transactions he held 176,000 Class A shares directly related to outstanding options and reported 0 Class A shares owned following the sales for the exercised tranches.
Form 144 filed for Amphenol Corporation (APH) reports a proposed sale of 88,000 common shares acquired on 09/08/2025 by exercise of options under a registered plan. The filing lists Morgan Stanley Smith Barney LLC as the broker and shows an aggregate market value of $9,735,941.60 for the shares, with approximately 1,220,921,111 shares outstanding. The filer indicates payment was made in cash on 09/08/2025 and reports no other sales in the past three months. The notice includes the required representation that the seller has no undisclosed material adverse information about the issuer.
Walter Luc, an officer and director of Amphenol Corporation (APH), reported a change in beneficial ownership on 08/29/2025. The Form 4 shows a gift (Code G) disposing of 18,048 shares of Class A common stock at a reported per-share price of $110.81. After the transaction, Mr. Luc is reported to beneficially own 433,742 shares, held directly. The filing was signed by a power of attorney on 09/02/2025. The document contains no earnings or other corporate action details; it solely discloses this insider transfer.